Literature DB >> 6157470

Multiple ventricular extrasystoles following administration of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA).

G Falkson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6157470

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  6 in total

1.  A phase II study of m-AMSA in patients with malignant mesothelioma.

Authors:  G Falkson; D A Vorobiof; H J Lerner
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

2.  Electrocardiogram abnormalities induced by amsacrine.

Authors:  R B Weiss; D Moquin; J D Adams; J D Griffin; H Zimbler
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

Review 3.  Cancer chemotherapy and cardiac arrhythmias: a review.

Authors:  Juan Tamargo; Ricardo Caballero; Eva Delpón
Journal:  Drug Saf       Date:  2015-02       Impact factor: 5.606

Review 4.  Myocardial diseases of animals.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

5.  Human tissue distribution of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (NSC 141549, AMSA).

Authors:  D J Stewart; G Zhengang; K Lu; N Savaraj; L G Feun; M Luna; R S Benjamin; M J Keating; T L Loo
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

6.  A phase II study of m-AMSA in patients with primary liver cancer.

Authors:  G Falkson; B Coetzer; D J Klaassen
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.